Truist Financial issued a 'buy' rating and lifted the price objective for James Hardie on August 18, 2026.
1 report, 1 independent
Updated Aug 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial issued a 'buy' rating and lifted the price objective for James Hardie on August 18, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
James Hardie
Irish building materials company
Nothing else this week.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Truist Financial and Citigroup provided buy ratings and price objectives for Crown stock.
- Financial institutions including Truist Financial, Royal Bank of Canada, and Renaissance Technologies issued rating updates and reported institutional holdings changes to the SEC.
- Multiple financial firms, including Keefe, Bruyette & Woods, Jefferies, and TD Cowen, adjusted price targets and ratings on September 24, 2026.
- Truist Financial increased its price objective on NETSTREIT (NTST) on September 8, 2026.
- Truist Financial disclosed trading activity and issued price objective reports related to Edwards Lifesciences.